Cas:124345-10-4 4-(S)-1-Des(methylamine)-1-oxo-2-(R,S)-hydroxy Sertraline manufacturer & supplier

Chemical Name:4-(S)-1-Des(methylamine)-1-oxo-2-(R,S)-hydroxy Sertraline

CAS.NO:124345-10-4

Synonyms:4-(3,4-Dichlorophenyl)-2-hydroxy-3,4-dihydro-2H-naphthalen-1-one

Molecular Formula:C₁₆H₁₂Cl₂O₂

Molecular Weight:307.17100

HS Code:2914700090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:451.1ºC at 760 mmHg

Density:1.41g/cm3

Index of Refraction:1.645

PSA:37.30000

Exact Mass:306.02100

LogP:4.07260

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 4-(3,4-Dichlorophenyl)-2-hydroxy-3,4-dihydro-2H-naphthalen-1-one chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-(3,4-Dichlorophenyl)-2-hydroxy-3,4-dihydro-2H-naphthalen-1-one physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-(3,4-Dichlorophenyl)-2-hydroxy-3,4-dihydro-2H-naphthalen-1-one Use and application,4-(3,4-Dichlorophenyl)-2-hydroxy-3,4-dihydro-2H-naphthalen-1-one technical grade,usp/ep/jp grade.

Related News: In a statement to Fierce Medtech, Innova said it has completed some corrective actions, while others are still underway, and that the U.S. recall was launched to reclaim tests distributed to employees, clinical studies and to customers for early evaluation. The company said it plans to seek an emergency use authorization and comply with all FDA requirements. 4-(S)-1-Des(methylamine)-1-oxo-2-(R,S)-hydroxy Sertraline manufacturer In a statement to Fierce Medtech, Innova said it has completed some corrective actions, while others are still underway, and that the U.S. recall was launched to reclaim tests distributed to employees, clinical studies and to customers for early evaluation. The company said it plans to seek an emergency use authorization and comply with all FDA requirements. 4-(S)-1-Des(methylamine)-1-oxo-2-(R,S)-hydroxy Sertraline supplier The move could force international drugmakers to further cut prices and enable copycat medicines to replace imported off-patent brands at faster pace. 4-(S)-1-Des(methylamine)-1-oxo-2-(R,S)-hydroxy Sertraline vendor Commonly used generic drugs: the products whose patents have expired and the generic drugs of many companies have participated in the competition, and the market demand is large. 4-(S)-1-Des(methylamine)-1-oxo-2-(R,S)-hydroxy Sertraline factory In a statement to Fierce Medtech, Innova said it has completed some corrective actions, while others are still underway, and that the U.S. recall was launched to reclaim tests distributed to employees, clinical studies and to customers for early evaluation. The company said it plans to seek an emergency use authorization and comply with all FDA requirements.